This tip sheet provides an overview of Medicaid Drug Utilization Review (DUR) Boards, including their role in evaluating medications and shaping state Medicaid drug coverage policies. It offers practical guidance for patients and advocates on when and how to engage with DUR Boards to help ensure rare disease treatments remain accessible and that patient experiences are considered in coverage decisions.
New Name, Same Commitment to Rare Diseases
The EveryLife Foundation for Rare Diseases has become The RARE Foundation! Read more about our new brand and how it unifies our advocacy work on behalf of the rare disease community.
